Clinical Trials Browser

Phase 2 × Urethral Neoplasms × Irinotecan × Clear all

NCT00066612 2012-11-02

S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy

Phase 2 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms